Three new decalin-type tetramic acid
analogues, pyrrolocins A (1), B (2), and
C (3), were defined
as products of a metabolic pathway from a fern endophyte, NRRL 50135,
from Papua New Guinea. NRRL 50135 initially produced 1 but ceased its production before chemical or biological evaluation
could be completed. Upon transfer of the biosynthetic pathway to a
model host, 1–3 were produced. All
three compounds are structurally related to equisetin-type compounds,
with 1 and 3 having a trans-decalin ring system, while 2 has a cis-fused decalin. All were active against Mycobacterium tuberculosis, with the trans-decalin analogues 1 and 3 exhibiting lower MICs than the cis-decalin analogue 2. Here we report the isolation, structure
elucidation, and antimycobacterial activities of 1–3 from the recombinant expression as well as the isolation
of 1 from the wild-type fungus NRRL 50135.